Back to Search
Start Over
T-lymphocyte-derived enkephalins reduce Th1/Th17 colitis and associated pain in mice
- Source :
- Journal of Gastroenterology, Journal of Gastroenterology, Springer Verlag, 2018, 53 (2), pp.215-226. ⟨10.1007/s00535-017-1341-2⟩
- Publication Year :
- 2017
- Publisher :
- Springer Science and Business Media LLC, 2017.
-
Abstract
- BACKGROUND:Endogenous opioids, including enkephalins, are fundamental regulators of pain. In inflammatory conditions, the local release of opioids by leukocytes at the inflammatory site inhibits nociceptor firing, thereby inducing analgesia. Accordingly, in chronic intestinal Th1/Th17-associated inflammation, enkephalins released by colitogenic CD4+ T lymphocytes relieve inflammation-induced visceral pain. The present study aims to investigate whether mucosal T-cell-derived enkephalins also exhibit a potent anti-inflammatory activity as described for exogenous opioid drugs in Th1/Th17-associated colitis.METHODS:The anti-inflammatory effects of endogenous opioids were investigated in both Th1/Th17-associated (transfer of CD4+CD45RBhigh T lymphocytes) and Th2-associated (oxazolone) colitis models in mice. Inflammation-induced colonic damage and CD4+ T cell subsets were compared in mice treated or not treated with naloxone methiodide, a peripheral antagonist of opioid receptors. The anti-inflammatory activity of T-cell-derived enkephalins was further estimated by comparison of colitis severity in immunodeficient mice into which naïve CD4+CD45RBhigh T lymphocytes originating from wild-type or enkephalin-knockout mice had been transferred.RESULTS:Peripheral opioid receptor blockade increases the severity of Th1/Th17-induced colitis and attenuates Th2 oxazolone colitis. The opposite effects of naloxone methiodide treatment in these two models of intestinal inflammation are dependent on the potency of endogenous opioids to promote a Th2-type immune response. Accordingly, the transfer of enkephalin-deficient CD4+CD45RBhigh T lymphocytes into immunodeficient mice exacerbates inflammation-induced colonic injury.CONCLUSIONS:Endogenous opioids, including T-cell-derived enkephalins, promote a Th2-type immune response, which, depending on the context, may either attenuate (Th1/Th17-associated) or aggravate (Th2-associated) intestinal inflammation.
- Subjects :
- 0301 basic medicine
enkephalin
Enkephalin
medicine.drug_class
T lymphocytes
Intestinal inflammation
Inflammation
enképhaline
(+)-Naloxone
lymphocyte
03 medical and health sciences
0302 clinical medicine
Opioid receptor
inflammation intestinale
Medicine
pain
Colitis
T-lymphocytes
Endogenous opioid
business.industry
Gastroenterology
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
Visceral pain
Enkephalins
medicine.disease
3. Good health
030104 developmental biology
Opioid
Immunology
douleur
medicine.symptom
business
030217 neurology & neurosurgery
medicine.drug
Subjects
Details
- ISSN :
- 14355922 and 09441174
- Volume :
- 53
- Database :
- OpenAIRE
- Journal :
- Journal of Gastroenterology
- Accession number :
- edsair.doi.dedup.....d238a757d558a8c8f1fd5f8a3adfb9e3
- Full Text :
- https://doi.org/10.1007/s00535-017-1341-2